Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture.
Perloff
M D
MD
von Moltke
L L
LL
Fahey
J M
JM
Daily
J P
JP
Greenblatt
D J
DJ
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D000230:Adenocarcinoma; D002219:Carbamates; D002461:Cell Line, Transformed; D003110:Colonic Neoplasms; D018432:Drug Resistance, Multiple / Q000235:genetics; D005663:Furans; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D019469:Indinavir / Q000494:pharmacology; D007559:Ivermectin / Q000494:pharmacology; D019888:Nelfinavir / Q000494:pharmacology; D019438:Ritonavir / Q000494:pharmacology; D019258:Saquinavir / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014700:Verapamil / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; C095108:amprenavir; D014747:Vinblastine; D019469:Indinavir; D007559:Ivermectin; D014700:Verapamil; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir